BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24122221)

  • 1. [Medicine from the computer].
    Andrae K; Durmaz V; Fackeldey K; Scharkoi O; Weber M
    Z Rheumatol; 2013 Oct; 72(8):809-13. PubMed ID: 24122221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medicine from the computer].
    Andrae K; Durmaz V; Fackeldey K; Scharkoi O; Weber M
    Anaesthesist; 2013 Jul; 62(7):557-61. PubMed ID: 23817844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Medicine from the computer].
    Andrae K; Durmaz V; Fackeldey K; Scharkoi O; Weber M
    Schmerz; 2013 Aug; 27(4):409-13. PubMed ID: 23903763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel analgesics through a drug repurposing strategy.
    Gazerani P
    Pain Manag; 2019 Jul; 9(4):399-415. PubMed ID: 30950770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical Pain Research: Can We Do Better?
    Clark JD
    Anesthesiology; 2016 Nov; 125(5):846-849. PubMed ID: 27575448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in computational prediction of drug absorption and permeability in drug discovery.
    Hou T; Wang J; Zhang W; Wang W; Xu X
    Curr Med Chem; 2006; 13(22):2653-67. PubMed ID: 17017917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel technologies for virtual screening.
    Lengauer T; Lemmen C; Rarey M; Zimmermann M
    Drug Discov Today; 2004 Jan; 9(1):27-34. PubMed ID: 14761803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational protein-ligand docking and virtual drug screening with the AutoDock suite.
    Forli S; Huey R; Pique ME; Sanner MF; Goodsell DS; Olson AJ
    Nat Protoc; 2016 May; 11(5):905-19. PubMed ID: 27077332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational Drug Design of Antineoplastic Agents Using 3D-QSAR, Cheminformatic, and Virtual Screening Approaches.
    Vucicevic J; Nikolic K; Mitchell JBO
    Curr Med Chem; 2019; 26(21):3874-3889. PubMed ID: 28707592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends and targets for treatment of pain, a pharmaceutical industry perspective.
    Haegerstrand A
    Acta Anaesthesiol Scand Suppl; 1998; 113():31-3. PubMed ID: 9932118
    [No Abstract]   [Full Text] [Related]  

  • 11. Computational methods for the design of effective therapies against drug resistant HIV strains.
    Beerenwinkel N; Sing T; Lengauer T; Rahnenführer J; Roomp K; Savenkov I; Fischer R; Hoffmann D; Selbig J; Korn K; Walter H; Berg T; Braun P; Fätkenheuer G; Oette M; Rockstroh J; Kupfer B; Kaiser R; Däumer M
    Bioinformatics; 2005 Nov; 21(21):3943-50. PubMed ID: 16144807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of second-generation P2X3 antagonists for treatment of pain.
    Ginnetti AT; Paone DV; Stauffer SR; Potteiger CM; Shaw AW; Deng J; Mulhearn JJ; Nguyen DN; Segerdell C; Anquandah J; Calamari A; Cheng G; Leitl MD; Liang A; Moore E; Panigel J; Urban M; Wang J; Fillgrove K; Tang C; Cook S; Kane S; Salvatore CA; Graham SL; Burgey CS
    Bioorg Med Chem Lett; 2018 May; 28(8):1392-1396. PubMed ID: 29548573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-directed combinatorial library design.
    Zhou JZ
    Curr Opin Chem Biol; 2008 Jun; 12(3):379-85. PubMed ID: 18328830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The challenges of translational research for analgesics: the state of knowledge needs upgrading and some uncomfortable deficiencies remain to be urgently addressed.
    Quessy SN
    J Pain; 2010 Jul; 11(7):698-700. PubMed ID: 20605748
    [No Abstract]   [Full Text] [Related]  

  • 15. From in silico target prediction to multi-target drug design: current databases, methods and applications.
    Koutsoukas A; Simms B; Kirchmair J; Bond PJ; Whitmore AV; Zimmer S; Young MP; Jenkins JL; Glick M; Glen RC; Bender A
    J Proteomics; 2011 Nov; 74(12):2554-74. PubMed ID: 21621023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual screening in drug design.
    Lill M
    Methods Mol Biol; 2013; 993():1-12. PubMed ID: 23568460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Computer-aided design of selective ligands binding to G protein-coupled receptors].
    Schmidt D; Kolb P
    Dtsch Med Wochenschr; 2013 Oct; 138(44):2260-4. PubMed ID: 24065450
    [No Abstract]   [Full Text] [Related]  

  • 18. Theoretical and practical considerations in virtual screening: a beaten field?
    Kontoyianni M; Madhav P; Suchanek E; Seibel W
    Curr Med Chem; 2008; 15(2):107-16. PubMed ID: 18220766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating cell-level kinetic modeling into the design of engineered protein therapeutics.
    Rao BM; Lauffenburger DA; Wittrup KD
    Nat Biotechnol; 2005 Feb; 23(2):191-4. PubMed ID: 15696150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtual Screening of Novel Glucosamine-6-Phosphate Synthase Inhibitors.
    Lather A; Sharma S; Khatkar A
    Comb Chem High Throughput Screen; 2018; 21(3):182-193. PubMed ID: 29600755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.